Moreover, other studies found that TGF-β1 actually reduced fractalkine mRNA and protein expression in glioma cells [61], which supports a complex interplay between the levels of these two molecules that may be dependent on the tissue or disease of interest. This evidence concerns the gene CX3CL1 and glioma.